These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8512657)

  • 21. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A; Schmekal B; Grafinger P; Biesenbach G
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term captopril therapy with no effect on glucose metabolism in patients with essential hypertension.
    Takasaki I; Shionoiri H; Hiroto S; Yasuda G; Gotoh E; Umemura S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):217S-220S. PubMed ID: 3046627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Captopril + hydrochlorothiazide versus captopril + nifedipine in the treatment of arterial hypertension in diabetes mellitus type II].
    Souvirón Rodríguez A; Martínez Morillo M
    Rev Esp Cardiol; 1992; 45(7):432-7. PubMed ID: 1439067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Dominguez JR; de la Calle H; Hurtado A; Robles RG; Sancho-Rof J
    Postgrad Med J; 1986; 62 Suppl 1():66-8. PubMed ID: 3534865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ; Ramos OL; Gross JL
    Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of captopril and captopril plus frusemide as antihypertensive agents in non-insulin dependent diabetes.
    Matthews DM; Wathen CG; Bell D; Collier A; Roulston JE; Clarke BF; Muir AL
    J Hum Hypertens; 1987 Jun; 1(1):19-23. PubMed ID: 3334054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.
    Ernsberger P; Johnson JL; Rosenthal T; Mirelman D; Koletsky RJ
    Am J Hypertens; 2007 Aug; 20(8):866-74. PubMed ID: 17679035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of angiotensin-converting enzyme inhibitor (alacepril) and calcium antagonist (nicardipine) in hypertensive non-insulin-dependent diabetic patients with microalbuminuria.
    Haisa S; Norii T; Takatori E; Goto A; Morioka S; Uchida K; Himei H
    J Diabet Complications; 1991; 5(2-3):162-4. PubMed ID: 1770031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy.
    Cheng IK; Ma JT; Yeh GR; Chan MK
    Int Urol Nephrol; 1990; 22(3):295-303. PubMed ID: 2210987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B; Vajo Z; Dachman W
    Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus.
    Rett K; Wicklmayr M; Tschollar W; Dietze G; Mehnert H
    Postgrad Med J; 1988; 64 Suppl 3():69-74; discussion 90-2. PubMed ID: 3074300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G; Mogensen CE; Groop LC; Pauls JF
    JAMA; 1994 Jan; 271(4):275-9. PubMed ID: 8295285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.